000			02089nam a22002537a 4500
999			_c8011 _d8011
001			MED 2013 0009
003			PILC
005			20240720152610.0
008			160505b2013 xxu||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _erda
041			_aenglish
050			_aMED 2013 0009
245			_aRisk factors associated with multi-drug resistant isolates among patients with ventilator-associated pneumonia admitted at FEU-NRMF Medical Center / _cJeru Faisal L. Usman.
260			_aFairview, Quezon City: _bDepartment of Internal Medicine, FEU-NRMF, _c2013.
300			_billustration, tables; _c(in folder)
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
504			_aIncludes bibliographical references.
520			_aAbstract: This study aims to identify the risk factors associated with multi-drug resistant pathogens among patients with ventilation - associated pneumonia admitted at FEU-NRMF medical center. Specifically, the clinical characteristics of patients with hospital acquired pneumonia with multi drug resistant pathogens were identified. The multi-drug resistant pathogens were likewise searched for From these data, an antibiogram susceptibility pattern of the most common multidrug resistant isolate will be determined. This is a Prospective observational cohort study. All adult patients admitted at either ICU of Pay/Charity Wards exhibiting clinically and bacteriologically documented VAP will be included in the study. The patients chart is reviewed and the data collected includes the patients baseline characteristics. The diagnosis of VAP is based on the 2005 American Thoracic Society Guidelines. Endotracheal tube aspirate will be collected, and sputum culture will be done. The potential factors for the development of VAP will then be subdivided into patient - related procedure - related and pharmacologic - related factors. The patients will be monitored until the day of discharge.
521			_aRESDM
700			_aUsman, Jeru Faisal L., MD. _eauthor
942			_2lcc _cRU